Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 871 (LINC00871) is a non-coding RNA gene located on chromosome 14q21.2[3][7]. It is classified as a long non-coding RNA (lncRNA), meaning it does not encode a protein but may regulate gene expression through various mechanisms at the transcriptional or post-transcriptional level[9]. LINC00871 has been identified as functionally relevant in diverse biological processes, including regulation of immune microenvironment, differentiation of T helper cells, immune exclusion in tumors, and association with prognosis in cancers such as breast cancer and colon cancer[4][8][10]. It is frequently considered in signatures for prognostic models rather than as a direct molecular target for drug therapy, and there are no known drugs that directly interact with or modulate LINC00871[4][8]. Its biological effects are attributed to its role in gene regulatory networks and immune modulation, rather than serving as a receptor, enzyme, or transporter.
Not applicable; no drugs are known to target LINC00871 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 871 (LINC00871).